Recursion’s Biotech Stock Surges 60% After NVIDIA’s $50 Million Investment to Propel AI-Based Drug Discovery Models
Recursion, a publicly listed biotech firm, immediately introduced that it has obtained a $50 million funding by NVIDIA, which was ...
Read more